Compugen Ltd (CGEN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

26 HAROKMIM STREET HOLON, ISRAEL 5885849

Develops computer hardware and software applications to enable scientists to enhance their research efforts in drug discovery, therapeutics and diagnostics. The company's Keddem Bioscience Ltd. is focused on small molecule drug discovery.

Data based on most recent fiscal year report
Market Cap217.303 Million Shares Outstanding51.13 Million Avg Volume265.779 Thousand
1-Yr BETA vs S&P TR1.22 Current Ratio5.04 Quick Ratio5.04
View SEC Filings from CGEN instead.
Q3 2018 All Institutions Hedge Funds 1
To trade CGEN now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 37 4 (0.39%)
Aggregate 13F shares on 09/30/2018: 11.121 Million 1.948 Million
Aggregate 13F shares on 06/30/2018: 10.654 Million 2.941 Million
Percent change: 4.39% -33.75%
Funds creating new positions: 8 1
Funds Adding to an existing position: 8 1
Funds closing out their position: 10 5
Funds reducing their position: 8 1
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding CGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments